2021
DOI: 10.1016/j.ctarc.2021.100474
|View full text |Cite
|
Sign up to set email alerts
|

Clinical characteristics of Hepatoid adenocarcinoma of the lung: Four case reports and literature review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
8
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(9 citation statements)
references
References 34 publications
0
8
0
Order By: Relevance
“…In recent years, some patients without elevated AFP levels have occasionally appeared. Most of the lesions in patients with primary HAL appear in the upper lobe of the lung, resulting in the symptoms and imaging findings of the patients being very similar to those of other types of lung cancer, but HE and immunohistochemical staining of the tumor pathology showed HCC-like features (Zhuansun et al, 2021). Therefore, to avoid misdiagnosis, CT examination and HE and immunohistochemical staining should be conducted together to help in the diagnosis (Terracciano et al, 2003).…”
Section: Discussion Interpretationmentioning
confidence: 99%
See 2 more Smart Citations
“…In recent years, some patients without elevated AFP levels have occasionally appeared. Most of the lesions in patients with primary HAL appear in the upper lobe of the lung, resulting in the symptoms and imaging findings of the patients being very similar to those of other types of lung cancer, but HE and immunohistochemical staining of the tumor pathology showed HCC-like features (Zhuansun et al, 2021). Therefore, to avoid misdiagnosis, CT examination and HE and immunohistochemical staining should be conducted together to help in the diagnosis (Terracciano et al, 2003).…”
Section: Discussion Interpretationmentioning
confidence: 99%
“…Second, if it expresses markers of liver differentiation, the abnormality in the patient should be diagnosed as HAL, no matter the AFP level is elevated or not. A thorough review of the published cases showed that patients with early diagnosis of HAL had longer postoperative survival, and the current treatment for HAL is the same as that for other lung cancers; radiotherapy and chemotherapy are effective treatments for patients with advanced HAL (Zhuansun et al, 2021). However, owing to the lack of analysis of gene mutations in HAL cases, the progress of new gene-targeted therapy has been limited.…”
Section: Discussion Interpretationmentioning
confidence: 99%
See 1 more Smart Citation
“…Moreover, HAL is mainly diagnosed by histopathology and immunohistochemistry, which must rule out primary HCC or other HAC metastasis to the lungs. 9,10 Due to non-specific clinical manifestations, HAL is often diagnosed at its advanced stage (stage III or IV), thereby resulting in shorter survival time. 7 HAL patients who undergo surgery have an average life expectancy between 7 months and 7 years and a 1-year survival rate of 55%.…”
Section: Discussionmentioning
confidence: 99%
“…HAL is indicated mainly by imaging that shows inhomogeneous masses in the upper lung fields; enhanced CT scans reveal homogeneous or heterogeneous density 5,8,9 . Thus, HAL is difficult to distinguish from other malignant tumours in the lung by imaging alone.…”
Section: Discussionmentioning
confidence: 99%